About: http://data.cimple.eu/news-article/0e01f08bf66df1fbd694efc3e7177a2e3c088cedc85eac97dde59687     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : schema:NewsArticle, within Data Space : data.cimple.eu associated with source document(s)

AttributesValues
rdf:type
schema:articleBody
  • AstraZeneca on Wednesday denied reports it was stockpiling coronavirus vaccines in the EU to export to Britain, after Italian inspectors found 29 million doses in a manufacturing plant. The discovery fuelled concerns in Brussels that the firm was not being transparent about its production, and came on the same day the bloc tightened its export control mechanism amid a row with the UK over supplies. But AstraZeneca said 16 million doses in the plant in Anagni in central Italy were destined for the EU and the other 13 million for the Covax programme, which supports poorer countries and has Brussels' support. EU officials did not dispute the numbers. "There are no exports currently planned other than to Covax countries," an AstraZeneca spokesperson said. The doses destined for Europe were waiting for inspection before being dispatched, and were expected to be delivered by the end of April. Media reports alleged that the firm planned to ship the vaccines to Britain. European capitals are irritated that the UK-based company managed to supply its British commitment smoothly, while falling far short of its promised deliveries to the EU. But a British government source denied that any of the Anagni doses were expected in the UK, and an Italian government official said they appeared to be destined for Belgium, a hub of vaccine production and distribution. The Italian plant performs "fill and finish", the process of putting vaccines produced elsewhere into vials and properly packaging them. "We suspected that AstraZeneca had more production capacity in Europe than they had accounted for," a European official told AFP, adding that industry commissioner Thierry Breton had asked Italy to investigate. The official said the EU would now check where the vaccines were set to be delivered to, and whether they were originally produced in plants authorised by the European Medicines Agency. The reports come as the EU said it would bolster rules on Covid-19 vaccine exports, making authorisations contingent on destination countries behaving fairly in return. EU officials said the scheme is not a "vaccine export ban" and does not target any country in particular -- though they called out AstraZeneca for falling far short on its deliveries to Europe. dc-burs/rmb/jv
schema:headline
  • Vaccine stock in Italy stirs EU suspicions
schema:mentions
schema:author
schema:datePublished
http://data.cimple...sPoliticalLeaning
http://data.cimple...logy#hasSentiment
http://data.cimple...readability_score
http://data.cimple...entionsConspiracy
Faceted Search & Find service v1.16.123 as of May 22 2025


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3241 as of May 22 2025, on Linux (x86_64-pc-linux-musl), Single-Server Edition (126 GB total memory, 8 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2026 OpenLink Software